BYAKANGELICIN T5813
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
BYAKANGELICIN,a main furanocoumarin constituent isolated and characterized as an aldose reductase inhibitor,and is effective for the treatment of sugar cataracts and diabetic neuropathy and hence might be useful as a lead compound for the development of n
CAS nr:
482-25-7
Purity:
98%
Molecular Weight:
334,32
SMILES:
COc1c2ccoc2c(OC[C@@H](O)C(C)(C)O)c2oc(=O)ccc12
Formula:
C17H18O7
Pathway:
Endocrinology/Hormones,Metabolism
Target:
Reductase,Reductase
